Reaction

Rapid Eye Movement Sleep Behaviour Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 394 reports · 15 co-occurring drugs

As of the last recalculation, Rapid Eye Movement Sleep Behaviour Disorder appears in 394 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is AMANTADINE (PRR 91.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Amantadine2591.191.2
Rasagiline Mesylate1889.589.6
Pimavanserin Tartrate5662.262.3
Escitslopram5051.951.9
Ropinirole1449.950.0
Rotigotine1349.149.1
Ziprasidone1546.746.8
Carbidopa And Levodopa3745.445.4
Levodopa1044.844.9
Escitalopram Oxalate5142.342.3
Methylphenidate1936.436.4
Donepezil Hydrochloride2131.931.9
Calcium, Magnesium, Potassium, And Sodium Oxybates531.131.1
Armodafinil1231.031.0
Sodium Oxybate2622.222.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.